SV Life Sciences has hired experienced venture capital investor Michael Balmuth as a partner in its healthcare services team not long after adding three new venture partners to its biotechnology investment division.
Prior to joining SVLS, Baluth worked as a general partner at Edison Ventures where he was head of the firm’s healthcare IT practice and a general partner at Summit Partners.
At Summit, Balmuth led the East Coast office for the Summit Accelerator Fund.
He has also worked at Broadview International, where he advised on M&A transactions and equity investments totalling over $1bn.
Balmuth started his career at IBM, where he was involved in sales, marketing, corporate development and systems engineering.
SVLS chairman Gene Hill said, “The vast knowledge he gained from investing in and developing software and information technologies across the healthcare industry will significantly strengthen SVLS’ diverse set of skills and competencies.”
In June SVLS appointed Dan Burgess, Ed Mascioli and Michael Mendelsohn as venture partners in its biotechnology investment team.
They will work on investing in innovative medicines, platform technologies and diagnostics addressing significant unmet medical needs.
Copyright © 2014 AltAssets